Infliximab, Infliximab-dyyb and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of Infliximab, Infliximab-dyyb and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: infliximab
Brand name: Inflectra, Remicade, Renflexis
Synonyms: InFLIXimab, Infliximab
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Infliximab, Infliximab-dyyb-Tafenoquine Succinate (Arakoda)
- Infliximab, Infliximab-dyyb-Tafenoquine Succinate (Krintafel)
- Infliximab, Infliximab-dyyb-Tafinlar
- Infliximab, Infliximab-dyyb-Tafluprost
- Infliximab, Infliximab-dyyb-Tafluprost ophthalmic
- Infliximab, Infliximab-dyyb-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-InFLIXimab-abda
- Tafenoquine (Prevention of Malaria Relapse)-Infliximab-abda Intravenous
- Tafenoquine (Prevention of Malaria Relapse)-Infliximab-dyyb
- Tafenoquine (Prevention of Malaria Relapse)-Infliximab-dyyb Intravenous
- Tafenoquine (Prevention of Malaria Relapse)-Infliximab-qbtx Intravenous
- Tafenoquine (Prevention of Malaria Relapse)-Influenza A (H1N1) 2009 Monovalent Vaccine